Literature DB >> 11064212

A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract.

M Kamba1, Y Seta, A Kusai, M Ikeda, K Nishimura.   

Abstract

The purpose of this study was to prepare tablets that could evaluate the destructive force in the gastrointestinal (GI) tract. Many factors are known to affect in vivo drug release from oral dosage forms. There is still relatively little information on the mechanical destructive force in the GI tract. Press-coated tablets with an extremely brittle outer layer were developed using a unique, highly hydrophobic Teflon powder that could be shaped with weak compression force. A marker drug contained in the tablets was released only when the tablets received a force larger than its predetermined crushing strength. We referred to this type of tablet as a 'destructive force dependent release system' (DDRS). A total of nine healthy, male subjects were orally administered the tablets under fed and/or fasting conditions. Tablets with a predetermined crushing strength of 1.50 N were crushed by all of the four subjects who took them under fed conditions and two of the five subjects under fasting conditions. Tablets with a crushing strength of 1.89 N were crushed by two of the six subjects who took them under fed conditions and none of the five subjects under fasting conditions. The range of mechanical destructive force in the human stomach was obtained.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064212     DOI: 10.1016/s0378-5173(00)00552-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

1.  A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach.

Authors:  Bertil Abrahamsson; Anupam Pal; Marie Sjöberg; Maria Carlsson; Emma Laurell; James G Brasseur
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

2.  An oral-controlled release drug delivery system for liquid and semisolid drug formulations.

Authors:  Dorota Haznar-Garbacz; Grzegorz Garbacz; Friederike Eisenächer; Sandra Klein; Werner Weitschies
Journal:  AAPS PharmSciTech       Date:  2011-09-15       Impact factor: 3.246

3.  A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms.

Authors:  Majde Takieddin; Reza Fassihi
Journal:  AAPS PharmSciTech       Date:  2014-10-02       Impact factor: 3.246

Review 4.  Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.

Authors:  Marilyn N Martinez; Jonathan P Mochel; Sibylle Neuhoff; Devendra Pade
Journal:  AAPS J       Date:  2021-04-27       Impact factor: 4.009

5.  Controlled porosity solubility modulated osmotic pump tablets of gliclazide.

Authors:  Arti Banerjee; P R P Verma; Subhash Gore
Journal:  AAPS PharmSciTech       Date:  2014-11-07       Impact factor: 3.246

6.  Understanding gastric forces calculated from high-resolution pill tracking.

Authors:  Bryan Laulicht; Anubhav Tripathi; Vincent Schlageter; Pavel Kucera; Edith Mathiowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 7.  Physiological parameters for oral delivery and in vitro testing.

Authors:  Deanna M Mudie; Gordon L Amidon; Gregory E Amidon
Journal:  Mol Pharm       Date:  2010-09-07       Impact factor: 4.939

8.  Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2011-04-09       Impact factor: 3.246

9.  Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions.

Authors:  Grzegorz Garbacz; Anna Kandzi; Mirko Koziolek; Jarosław Mazgalski; Werner Weitschies
Journal:  AAPS PharmSciTech       Date:  2013-12-03       Impact factor: 3.246

10.  In vivo performance of an oral MR matrix tablet formulation in the beagle dog in the fed and fasted state: assessment of mechanical weakness.

Authors:  Fiona McInnes; Nicola Clear; Michael Humphrey; Howard N E Stevens
Journal:  Pharm Res       Date:  2007-10-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.